The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...

LifeArc Ventures, which invests in innovative early-stage life science companies as part of LifeArc, today announced substantial progress ...

PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s ...

Botulinum toxin type A (BoNT-A), commonly known as Botox, has emerged as a promising option for managing multiple sclerosis (MS ... By targeting specific areas, Botox relaxes overactive muscles ...

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD ... While it can cause similar symptoms to multiple sclerosis (MS), it’s recognized as a distinct condition. Keep reading to learn ...

Jeffrey V. Matous, MD, discusses how best practices in transitioning care between academic and community centers can enhance patient outcomes when receiving bispecific antibodies, and the critical ...

Long-term safety data in MS patients for the highly specific ... IgG4κ antibody raised against α4-integrin (CD49d) was approved for the treatment of relapsing-remitting multiple sclerosis ...